Treatments

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Country Product Indication Sponsor Date
Girentuximab Renal cancer Heidelberg Pharma AG;101 Schriesheimer Stra�e;Ladenburg March 22, 2001
Unconjugated Chimeric (human-murine) G250 IgG monoclonal antibody Renal cancer Wilex Biotechnology GmbH;Grillparzerstrasse 10B, 81675 Munich; March 22, 2001
Recombinant fusion protein of Mycobacterium bovis BCG Hsp65 and HPV16 E7 Recurrent respiratory papillomatosis StressGen Biotechnologies, Inc. is now Nventa;Nventa Biopharmaceuticals Corporation, 6055 Lusk Boulevard;San Diego, California, 19426 March 19, 2001
Vasoactive intestinal peptide Acute Respiratory Distress Syndrome mondoBIOTECH;Europark, FL - 9490 Vaduz; March 9, 2001
Coenzyme Q10 Huntington disease Integrative Therapeutics, Inc.;825 Challenger Drive;Green Bay, Wisconsin, 54311 March 5, 2001
Eculizumab Idiopathic membranous glomerular nephropathy Alexion Pharmaceuticals, Inc.;352 Knotter Drive;Cheshire, Connecticut, 06410 March 5, 2001
Busulfan Intrathecal therapy for neoplastic meningitis SuperGen, Inc.;4140 Dublin Boulevard;Dublin, California, 94568 March 5, 2001
Docosahexanoic acid-paclitaxel Hormone-refractory prostate cancer Luitpold Pharmaceuticals, Inc.;One Luitpold Drive;Shirley, New York, 11976 March 5, 2001
Recombinant Human Alpha-Fetoprotein (rhAFP) Myasthenia gravis Myasthenia gravis Alpha Cancer Technologies, Inc.;MaRS Discovery District, South Tower, 200-101 College St.;Toronto, Ontario February 22, 2001
Medroxyprogesterone acetate Immune thrombocytopenic purpura ZaBeCor Pharmaceutical Company, LLC;821 Westview Street;Philadelphia, Pennsylvania, 19119 February 22, 2001
B Lymphocyte Stimulator Common variable immunodeficiency Human Genome Sciences, Inc.;9410 Key West Avenue;Rockville, Maryland, 20850 February 21, 2001
Pyruvate Interstitial lung disease Cellular Sciences, Inc;84 park Avenue, P.O. Box 968;Flemington, New Jersey, 08822 February 21, 2001
Nitroprusside Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage Thomas, MD, Jeffrey Evan;Thomas Jefferson University and Wills Neurosensory, 834 Walnut Street, Suite 650;Philadelphia, Pennsylvania, 19107 February 21, 2001
Alendronate disodium Gaucher disease Richard J. Wenstrup, M.D.;Division of Human Genetics, Children's Hospital Research Foundation;Cincinnati, Ohio, 45229 February 13, 2001
Virulizin Pancreatic cancer ZOR Pharmaceuticals, LLC;100-A Eastwood Center Drive, Suite 118;Wilmington, North Carolina, 28403 February 1, 2001
Imatinib Chronic myeloid leukemia Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 January 31, 2001
Novel Acting Thrombolytic (NAT) Peripheral arterial occlusion (PAO) Nuvelo, Inc. Inc.;201 Industrial Road, Suite 310;San Carlos, California, 94070 January 26, 2001
Synthetic Human Parathyroid Hormone 1-34 Hypoparathyroidism Rare Disease Therapeutics, Inc.;2550 Meridian Blvd;Nashville, Tennessee, 37217 January 26, 2001
MTC-DOX for Injection Hepatocellular Carcinoma FeRx Incorporated;4330 La Jolla Village Drive, Suite #250;San Diego, California, 92122 January 3, 2001
N-acetylcysteinate Lysine Cystic fibrosis Galephar Pharmaceutical Research, Inc.;Road 198, No. 100 km. 14.7, Juncos Industrial Park;Juncos December 27, 2000
Tiazofurin (2-Beta-D-ribofuranosyl-4-thiazolecarboxamide) Chronic myeloid leukemia Valeant Pharmaceuticals North America;3300 Hyland Avenue;Costa Mesa, California, 92626 December 27, 2000
N2′-deacetyl-N2′-(3-mercapto-1-oxopropyl)-Maystansine-Conjugated Humanized C242 Monoclonal Antibody Pancreatic Cancer SmithKline Beecham Pharmaceuticals;1250 S. Collegeville Road;Collegeville, Pennsylvania, 19426 December 7, 2000
Cyclosporine in combination with omega-3 polyunsaturated fatty acids Prevention of solid organ graft rejection RTP Pharma Corporation;200 Westpark Corporate Center, 4364 South Alston Avenue;Durham, North Carolina, 27713 December 6, 2000
Gavilimomab Graft Versus Host Disease Amgen;One Amgen Center Drive, Mail Stop 17-2-A;Thousand Oaks, California, 91320 November 20, 2000
Technetium Tc99m rh-Annexin V Diagnosis or assessment of rejection status in heart, heart-lung, single lung, or bilateral lung transplants Theseus Imaging Corporation;124 Mount Auburn Street, Suite 200 North;Cambridge, Massachusetts, 02138 November 3, 2000